Turn Therapeutics Inc.
NASDAQ:TTRXBiotechnology
-$0.17 today
- Market cap
- $271.79M
- Beta
- 2.77
- P/E (TTM)
- -45.0
- EPS (TTM)
- -$0.13
Volume 0.05M
Average 0.04M
TTRX Other Non-current Assets
Long-term assets not reported separately.
Turn Therapeutics Inc.NASDAQ: TTRX
Other Non-current Assets · Q1 FY2026 · quarter ended Mar 2026
Other non-current assets of $6.2M in Q1 FY2026
Q1 FY2026 other non-current assets was $6.2M.
Context
- Other non-current assets amounted to 33.3% of total assets at the end of Q1 FY2026.
- Other non-current assets increased in 1 of the last 2 fiscal years.
- FY2025 was the highest annual figure in the 3 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Non-current Assets history
USD · from the balance sheet
- Latest · FY2025
- 6.04M USD
- Year-over-year change
- +70322.1%
- 2-year CAGR
- +2553.7%
| Period | Period end | Other Non-current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 6.04M | +70322.1% |
| FY2024 | 2024-12-31 | 8.58K | +0.0% |
| FY2023 | 2023-12-31 | 8.58K | — |
Other Non-current Assets vs competitors
How TTRX compares with its peers on the latest reported figures
- TTRX's Mar 2026 other non-current assets of $6.2M is the highest of the 9 companies compared; the peer median is $16.88K.
- Other non-current assets amounts to 33.3% of total assets for TTRX, versus a peer median of 0.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
TTRXTurn Therapeutics Inc. | Mar 2026 | $6.2M | — | — | 33.3% |
| Mar 2026 | $4.32M | -39.6% | +49.6% | 1.6% | |
| Mar 2026 | $1.16M | — | — | 0.7% | |
| Mar 2026 | $213K | -80.6% | — | 0.1% | |
| Mar 2026 | $33.77K | — | +594.4% | 0.1% | |
IRDOpus Genetics, Inc. | Mar 2026 | $0 | — | — | 0.0% |
| Mar 2026 | $0 | — | — | 0.0% | |
| Apr 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding TTRX) | $16.88K | -60.1% | +322.0% | 0.1% | |
Competitors are the stored peer set for TTRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Turn Therapeutics Inc.
NASDAQ:TTRX
Intrinsic Alpha fair value
Locked
Current Price
$8.89
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.